MedPath
NMPA Product

Compound Sulfadiazine Tablets

Product approved by National Medical Products Administration (CN)

Basic Information

Compound Sulfadiazine Tablets

复方磺胺嘧啶片

磺胺嘧啶0.4g,甲氧苄啶50mg

片剂

Regulatory Information

国药准字H63020104

Approved

化学药品

May 27, 2020

Company Information

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath